Since this alteration does not have a known pathogenic association and other molecular alterations in this tumor were characteristic of an IDH-wildtype infiltrating astrocytoma, the mutation was regarded as clinically insignificant and not diagnostic of the IDH-mutated class of tumors. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).